Chronic kidney disease – Part 2: The evolution of evidence-based treatments from Stage 1 to 4 (Google Doctor Who?)

Présenté par Søren Boysen D.M.V., Dipl. ACVECC, Serge Chalhoub B. Sc., D.M.V., Dipl. ACVIM (médecine interne des animaux de compagnie)

Questionnaire de formation continue

Crédit de formation continue : 1

Nom

Questions

1. Which of the IRIS CKD stages has the most recommendations? *
2. When first diagnosing a cat with CKD, what treatments should be prioritized? *
3. Which hormone could potentially help diagnose kidney disease the earliest and help with identifying disease progression? *
4. Which phosphate binder is associated with toxicities related to lethargy, weakness and difficulty walking? *
5. What are the primary indications for sucralfate or famotidine in cats with CKD? *
6. What level of renal proteinuria as measured by UPC may be associated with the lowest risk for CKD progression? *
7. Which hormone has been called the hunger hormone? *
8. What is the most serious complication and limiting factor of erythrocyte-stimulating agents? *
9. When should subcutaneous fluids be used? *
10. When it comes to meloxicam usage and CKD, which statement is most accurate? *